OptimizeRx OPRX Preferred Stock, Par or Stated Value Per Share
Preferred Stock, Par or Stated Value Per Share at other companies
Other financials
Where this comes from
Reported directly by OptimizeRx in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockParOrStatedValuePerShare.
The official record: OptimizeRx’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about OptimizeRx's preferred stock, par or stated value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is OptimizeRx's preferred stock, par or stated value per share?
- OptimizeRx (OPRX) reported preferred stock, par or stated value per share of $0 in Q1 2026.
- How has OptimizeRx's preferred stock, par or stated value per share changed year-over-year?
- OptimizeRx's preferred stock, par or stated value per share decreased by 0.0% year-over-year, from $0 to $0.
- What is the long-term trend for OptimizeRx's preferred stock, par or stated value per share?
- Over 5 years (2020 to 2025), OptimizeRx's preferred stock, par or stated value per share has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.